Biomarin Pharmaceutical Inc (BMRN)
Interest coverage
| Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Earnings before interest and tax (EBIT) (ttm) | US$ in thousands | 689,643 | 850,797 | 685,960 | 554,102 | 407,044 | 315,083 | 253,938 | 205,304 | 165,948 | 123,275 | 87,420 | 164,953 | 116,157 | 71,092 | 50,355 | -60,606 | -32,721 | -42,050 | -94,770 | -13,535 |
| Interest expense (ttm) | US$ in thousands | 10,698 | 11,087 | 11,982 | 12,666 | 16,187 | 16,998 | 17,179 | 17,335 | 14,863 | 15,763 | 15,867 | 15,970 | 16,190 | 15,381 | 15,339 | 15,337 | 16,240 | 21,967 | 26,198 | 29,309 |
| Interest coverage | 64.46 | 76.74 | 57.25 | 43.75 | 25.15 | 18.54 | 14.78 | 11.84 | 11.17 | 7.82 | 5.51 | 10.33 | 7.17 | 4.62 | 3.28 | -3.95 | -2.01 | -1.91 | -3.62 | -0.46 |
September 30, 2025 calculation
Interest coverage = EBIT (ttm) ÷ Interest expense (ttm)
= $689,643K ÷ $10,698K
= 64.46
Peer comparison
Sep 30, 2025
Company name
Symbol
Interest coverage
Biomarin Pharmaceutical Inc
BMRN
64.46
Arrowhead Pharmaceuticals Inc
ARWR
0.93
Regeneron Pharmaceuticals Inc
REGN
123.21